Losartan: A Viewpoint by Sverre E. Kjeldsen.
- Published in:
- American Journal of Cardiovascular Drugs, 2003, v. 3, n. 5, p. 378, doi. 10.2165/00129784-200303050-00009
- By:
- Publication type:
- Article
Works matching IS 11753277 AND DT 2003 AND VI 3 AND IP 5
Results: 10
1
2
Losartan: In the Reduction of Stroke Risk in Patients with Hypertension and Left Ventricular Hypertrophy.
- Published in:
- American Journal of Cardiovascular Drugs, 2003, v. 3, n. 5, p. 371, doi. 10.2165/00129784-200303050-00008
- By:
- Publication type:
- Article
3
Assessment of Anti-Ischemic and Antianginal Effect at Trough Plasma Concentration and Safety of Trimetazidine MR 35mg in Patients with Stable Angina Pectoris: A Multicenter, Double-Blind, Placebo-Controlled Study.
- Published in:
- American Journal of Cardiovascular Drugs, 2003, v. 3, n. 5, p. 361, doi. 10.2165/00129784-200303050-00007
- By:
- Publication type:
- Article
4
ACE Inhibition with Moexipril: A Review of Potential Effects Beyond Blood Pressure Control.
- Published in:
- American Journal of Cardiovascular Drugs, 2003, v. 3, n. 5, p. 351, doi. 10.2165/00129784-200303050-00006
- By:
- Publication type:
- Article
5
Smoking Cessation for Patients with Cardiovascular Disease: What is the Best Approach?
- Published in:
- American Journal of Cardiovascular Drugs, 2003, v. 3, n. 5, p. 339, doi. 10.2165/00129784-200303050-00005
- By:
- Publication type:
- Article
6
The Role of Lipids in the Development of Diabetic Microvascular Complications: Implications for Therapy.
- Published in:
- American Journal of Cardiovascular Drugs, 2003, v. 3, n. 5, p. 325, doi. 10.2165/00129784-200303050-00004
- By:
- Publication type:
- Article
7
Immunosuppressive Therapy for Heart Failure: A Guide to Patient Selection.
- Published in:
- American Journal of Cardiovascular Drugs, 2003, v. 3, n. 5, p. 321, doi. 10.2165/00129784-200303050-00003
- By:
- Publication type:
- Article
8
Clinical Potential of Advanced Glycation End-Product Inhibitors in Diabetes Mellitus.
- Published in:
- American Journal of Cardiovascular Drugs, 2003, v. 3, n. 5, p. 315, doi. 10.2165/00129784-200303050-00002
- By:
- Publication type:
- Article
9
Spotlight on Abciximab in Patients with Ischemic Heart Disease Undergoing Percutaneous Coronary Revascularization.
- Published in:
- American Journal of Cardiovascular Drugs, 2003, v. 3, n. 5, p. 381, doi. 10.2165/00129784-200303050-00011
- By:
- Publication type:
- Article
10
Hyperuricemia and Adverse Outcomes in Cardiovascular Disease: Potential for Therapeutic Intervention.
- Published in:
- American Journal of Cardiovascular Drugs, 2003, v. 3, n. 5, p. 309, doi. 10.2165/00129784-200303050-00001
- By:
- Publication type:
- Article